brgf- Investment information

PRF-BRGF SYSTEM

We aim to become the top choice for a safer PRF system. Our process combines techniques from various fields to ensure safety and compliance with medical device regulations.

The Market

The Current PRF market is 54 million in 2024. PRF market is expected to grow as the bone graft and dental implants market grows because PRF is used by dentists placing bone grafts and dental implants.

The global dental bone graft market is expected to reach $1.4 billion by 2030, growing at a CAGR of 9.5% from 2023 to 2030 ¹. Source

The global dental implants market was valued at $4.99 billion in 2023 and is expected to reach $9.62 billion by 2030, growing at a CAGR of 9.8% from 2024 to 2030 ¹. Source

The Needs & Our Solution

Current device deficiencies are solved with our unique patented devices to comply with the PRF blood components laws and federal regulations for:
1- Sterility of blood tubes to process PRF
2- Plain tubes without additives or coats
3- No glass tubes unless Protected with puncture-resistant material. OSHA GLASS TUBES LAW .
OSHA law mandates replacement for new safer medical devices.

Patent granted and patents pending globally for exclusivity for 20 years or more. New pending patents in progress.

Returns & Exit Strategy Plan

Great returns are expected in the first year after FDA clearance, which will take ten months.
Exit strategies include:
1- Sale to a multinational implants or medical device company
2- Go to market generating substantive returns
3- Go public after three years

Another option to explore is patent licensing to implants and medical device companies.

PRF-BRGF SYSTEM

PRF-BRGF Competition

Our PRF system, as the new standard of care for PRF, will be the only PRF system in the market that, with our patented technology, complies with the FDA and all federal regulations for blood purity, safety, and sterility to avoid PRF contamination.
OSHA law mandates the replacement of prior devices with new, safer medical devices.

PRF-BRGF Advantages

Patented unique devices. Performance testing, Biocompatibility, sterility, and endobacterial batch testing to ensure safety and compliance.
OSHA law mandates replacement for new safer medical devices.
Unbeatable Low-cost supplies to doctors

PRF-BRGF Limitations & Status

Required tests have taken time as normal in the medical device industry. We are a starter company using our own resources, working hard at the final stages of tests to obtain clearance and go to market in approximately 10 to 12 months and fulfill orders pending FDA clearance.

PRF-BRGF SYSTEM medical device

Work Process – Status

01

Development – Completed

We work with manufacturers to obtain the system components as expected to make sure that safety and compliance are in order.

02

We are working on the final tests required. FDA clearance is expected to be in approximately 10 months as of 4/5/2024

03

Go to Market – Pending on clearance

We have centrifuges and other components of the system in stock and ready to go to market as soon as we obtain FDA clearance

BRGF

IR CONTACTS

Corporate Office

Biomedical Regenerative GF,LLC.

3401 N.Federal Hwy. Suite 220
Boca Raton, FL 33431
USA

561-674-6639

Investor Relations

Biomedical Regenerative GF,LLC.

561-674-6639

Transfer Agent

Attorney: Medderos Legal, PLLC.
7000 W Palmetto Park Rd Suite 210, Boca Raton, FL 33433

561-654-4725
diana@miplegal.com
https://www.mederoslegal.com/index.html